Close Bookmark and Share This Page

Save to Browser Favorites / Bookmarks

Ask backflip blinklist BlogBookmark Bloglines BlogMarks Blogsvine BuddyMarks BUMPzee! CiteULike Connotea del.icio.us

Digg diigo DotNetKicks DropJack dzone Facebook Fark Faves Friendsite folkd.com Furl Google

Jamespot Jeqq Kaboodle kirtsy linkaGoGo LinkedIn Ma.gnolia Mister Wong Mixx MySpace Netvouz Newsvine

oneview OnlyWire PlugIM Propeller Reddit Segnalo Shoutwire Simpy Slashdot Surphace Sphinn Spurl

Squidoo StumbleUpon Technorati ThisNext Twitter Webride Windows Live Yahoo!

Email This to a Friend

  Link HTML: 

 Permalink: 

 If you like this then please subscribe to the RSS Feed.

Powered by Bookmarkify™

More »

Here are today’s results on these stocks which we brought to you.

CTIC UP .0065

MBLX UP 30 CENTS

MATK UP 47 CENTS

VICL UP .01 CENT

CLDA UP 62 CENTS

What better results do you want than this except for our paid Premium service

regards

Don

Shares of Cell Therapeutics Rank the Highest in terms of Short Interest in the Biotechnology Industry (CTIC, MBLX, MATK, VICL, CLDA)

Below are the top five companies in the Biotechnology industry as measured by the short interest ratio. A higher short interest ratio may indicate the potential for a sizeable short squeeze.
Cell Therapeutics (NASDAQ:CTIC) has a short interest ratio of 28.1 based on average daily volume of 2 million shares and 66.6 million shares short. That equates to 8.8% of the 758.5 million shares outstanding.
Metabolix (NASDAQ:MBLX) has a short interest ratio of 23.5 based on average daily volume of 206,000 shares and 4.9 million shares short. That equates to 18.1% of the 26.9 million shares outstanding.
Martek Biosciences (NASDAQ:MATK) has a short interest ratio of 22.5 based on average daily volume of 282,000 shares and 6.4 million shares short. That equates to 19% of the 33.5 million shares outstanding.
Vical (NASDAQ:VICL) has a short interest ratio of 22.4 based on average daily volume of 192,000 shares and 4.3 million shares short. That equates to 7.7% of the 56.2 million shares outstanding.
Clinical Data (NASDAQ:CLDA) has a short interest ratio of 21.9 based on average daily volume of 112,000 shares and 2.5 million shares short. That equates to 8.3% of the 29.9 million shares outstanding.
SmarTrend is bearish on shares of MBLX and our subscribers were alerted to Sell on July 30, 2010 at $14.31. The stock has fallen 21.9% since the alert was issued.

Regards,

Don